Toxic-allergic syndrome caused by ingestion of rapeseed oil denatured with aniline.
about
Pharmacogenetic profile of xenobiotic enzyme metabolism in survivors of the Spanish toxic oil syndrome.Neurologic outcomes of toxic oil syndrome patients 18 years after the epidemic.Clinicoepidemiological, toxicological, and safety evaluation studies on argemone oilOn-Line HPLC-UV-mass spectrometry and tandem mass spectrometry for the rapid delineation and characterization of differences in complex mixtures: a case study using toxic oil variants.Chronic juvenile toxic epidemic syndrome.Antinuclear antibodies in the relatives and spouses of patients with systemic sclerosis.Tryptophan-induced eosinophilia-myalgia syndrome.Epidemiology of scleroderma.Dietary pulmonary hypertension.Toxic oil syndrome (TOS). Foreword.Short-term adverse effects in humans of ingested mineral oils, their additives and possible contaminants--a review.Toxicology and epidemiology: improving the science with a framework for combining toxicological and epidemiological evidence to establish causal inferenceCase series and exposure series: the role of studies without controls in providing information about the etiology of injury or diseaseAtypical systemic sclerosis following exposure to vinyl chloride monomer. A case report and review of the cutaneous aspects of vinyl chloride disease.Eosinophilic fasciitis.Pulmonary vascular lesions in the toxic oil syndrome in SpainEvaluation and differential diagnosis of marked, persistent eosinophilia.Environmental factors and lupus: are we looking too late?Early environmental exposure and the development of lupus.C/EBPβ-Thr217 Phosphorylation Stimulates Macrophage Inflammasome Activation and Liver Injury.Scleroderma-like fibrosing disorders.Drug-induced rheumatic syndromes. Diagnosis, clinical features and management.Inclusion body myofibroblasts other than those seen in recurring digital fibroma of childhood.Chemical-induced autoimmune reactions and Spanish toxic oil syndrome. Focus on hydantoins and related compounds.The application of clinical toxicology.Sclerosing dermatoses.Aniline Induces Oxidative Stress and Apoptosis of Primary Cultured Hepatocytes.The toxic oil syndrome.Pathology of a new toxic syndrome caused by ingestion of adulterated oil in Spain.Pulmonary hypertension: newer concepts in diagnosis and management.Human adjuvant-related syndrome or autoimmune/inflammatory syndrome induced by adjuvants. Where have we come from? Where are we going? A proposal for new diagnostic criteria.The Spanish toxic oil syndrome: Some explanations for the pathology and an appraisal of the similarities with other episodes of food adulteration.Immunogenicity of fatty acid anilides in rabbits and the pathogenesis of the Spanish toxic oil syndrome.Chronic myeloid leukaemia and allogenic bone marrow transplantation in a patient with toxic oil syndrome.[Eosinophilia myalgia syndrome in administration of L-tryptophan].Proteotyping of human haptoglobin by MALDI-TOF profiling: Phenotype distribution in a population of toxic oil syndrome patients.Development of pancellular toxicity in guinea pig lung by ingestion of oleylanilide.Quality of life, disability and handicap in patients with toxic oil syndrome.Studies on toxic oil syndrome: development of an enzyme-linked immunosorbent assay for 3-(N-phenylamino)propane-1,2-diol in human urine.A study of scleroderma in South Australia: prevalence, subset characteristics and nailfold capillaroscopy.
P2860
Q24812002-9AE21B8A-CA73-4CA8-8D93-508E65708290Q24815675-70B74454-75FD-49F2-B6E8-E3EE12A17B38Q28241239-C18C0604-FD5C-424B-84E4-F9186554B55BQ31107807-12A205CE-1D98-413A-A328-42EB57A4A8D7Q33555679-ED2C221A-F98F-451C-B9AC-ACC2AB0150C9Q33556986-6C9018E3-4229-4981-8CCF-39A7C1F56C25Q33558518-E9ADA405-8F7A-4435-896A-5FAE015B1304Q33631736-BCE5E1CB-0E08-41F5-973E-F9FE0818EFE3Q33789022-E4069A93-8B1D-491F-9FCC-4BDBD7CD675EQ33964338-D2A4E784-B8DE-449F-A480-E058D4C06C41Q33964343-9891E1E3-1B39-434C-98C1-25BD9FEFB665Q35161424-615F6F5D-481A-4102-B549-F0345F6E9407Q35385603-66C7DC06-503F-4F41-A636-FDA87D0E330DQ35545081-6143F408-B5A5-4859-A48C-0BAFD6E9B5D4Q35976418-169EAAED-8EC5-44C1-B1DB-2D2881B784F0Q36131409-58CA9428-0EA2-40B0-9465-8A305297B628Q36176737-6DB8BB04-BCB7-4225-B286-BDA8E96C2749Q36204302-6308FF05-B0BA-47D3-AC13-A4145E528639Q36677045-33033B3B-9971-42D2-9DF9-5E0FC79509E6Q36789815-BC669D2B-EF4F-4C21-A247-F54C0071AA89Q37105804-0B62849D-CB6C-4D72-B2BD-6B3C5A13A95FQ38217900-11404E41-58CB-4494-B59B-712FF7BEFBFBQ39339836-62F536E7-EEFD-4373-AB32-D4E0C32266ADQ39522617-E15166B0-F932-4AC9-B8C3-341133C50DA5Q39673589-D16D5FBA-FD9D-4435-9BD6-DF4E24CE4F46Q39832561-D249088B-3DA2-49F4-B2B0-E3295D6B0A92Q40359431-01F57999-8C4E-4BAD-9DCD-8D9CF3D63D76Q40655723-E1BBC802-E979-4158-B3A1-B46F00E72B51Q40847312-ABF5E99D-16B9-419E-BAE9-4326A281B4E1Q40886094-1E0464CA-014E-400A-87B6-44545887010CQ41152702-D60D3A43-6217-42D0-BF44-C444452B94A9Q42086880-1F5EE45D-BA9E-49F7-8FE5-CF359F11CA43Q42243842-9B84E63D-9236-42FD-B696-C22677FFFC03Q43239031-8CAE3634-A97D-474E-B4A5-286FDCA4F895Q44054524-8B5BB245-C526-4508-A5A6-1AA2F2A9DFF2Q44256806-EA87F4D5-F1AA-4908-BE11-76B9DB2358F7Q46383904-4A0F8A85-7E7C-4CC9-8203-6BCCB6E93B9BQ46519723-686C6877-6C2C-4F2A-A3D5-68F6F1DC70B9Q46640148-7ED4CE8A-BB67-4825-8D8E-6F77D5DB28BFQ47189771-B32677EB-4E7E-4546-A7B5-B7173A8B99C3
P2860
Toxic-allergic syndrome caused by ingestion of rapeseed oil denatured with aniline.
description
1981 nî lūn-bûn
@nan
1981年の論文
@ja
1981年学术文章
@wuu
1981年学术文章
@zh-cn
1981年学术文章
@zh-hans
1981年学术文章
@zh-my
1981年学术文章
@zh-sg
1981年學術文章
@yue
1981年學術文章
@zh
1981年學術文章
@zh-hant
name
Toxic-allergic syndrome caused by ingestion of rapeseed oil denatured with aniline.
@en
type
label
Toxic-allergic syndrome caused by ingestion of rapeseed oil denatured with aniline.
@en
prefLabel
Toxic-allergic syndrome caused by ingestion of rapeseed oil denatured with aniline.
@en
P1433
P1476
Toxic-allergic syndrome caused by ingestion of rapeseed oil denatured with aniline.
@en
P2093
J M Tabuenca
P304
P356
10.1016/S0140-6736(81)90949-1
P407
P577
1981-09-01T00:00:00Z